Visalytics
Visalytics
approved EB-2 (NIW)

Research Health Scientist

Pharmaceutical Science · China · 2023-02-02

Processing Time
110 days
Decision Date
2023-02-02
Location
Illinois
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to conduct research combining pharmacoepidemiology, pharmacoeconomics, and health outcomes science to identify treatment risks and prescribing patterns. Her work focuses on uncovering disease mechanisms and patient outcomes in chronic conditions like COPD, liver disease, and breast cancer to inform better diagnostic and therapeutic strategies. The endeavor aims to improve healthcare delivery efficiency and public health innovation within the United States.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses public health challenges and the need for cost-effective care in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic record, 26 publications, and 187 citations demonstrate her capability to lead this research.

3 Waiver of Job Offer/Labor Certification Met

The petitioner's unique contributions to pharmaceutical science make her an asset that outweighs the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in pharmaceutical outcomes and policy and a strong record of 26 peer-reviewed journal articles and 20 abstracts. Her work garnered 187 citations, with several papers ranked in the top 10-20% of their field, and she completed 21 peer reviews for leading medical journals. These metrics satisfied the Dhanasar prongs by demonstrating the national importance of her research and her well-positioned status to advance it.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Conference Presentations
Judging Experience
Original Contributions

Similar Cases

Others

Pharmaceuticals · South Korea

WeGreened EB-2 (NIW) approved
54 days 2025-03-24
The petitioner proposes to continue her research in pharmaceutical science by integrating advanced technologies and computational approaches to develop novel drug candidates. Her work focuses on improving drug delivery systems to create more effective, affordable, and stable medications for chronic diseases including cancer, diabetes, hypertension, and neurodegenerative diseases.
View Case

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
New York 169 days 2025-04-09
The petitioner proposes to continue research in the development of pharmacokinetics (PK) and pharmacodynamics (PD) studies, specifically focusing on the targeted delivery of anti-tumor and antimicrobial medications. This work involves synthesizing bioactive polymers, spatial metabolomics, and protein engineering to improve therapeutic efficacy. The endeavor aims to advance precision medications that reduce side effects for challenging diseases.
View Case

Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
Maryland 42 days 2025-01-10
The petitioner proposes to continue his research in the field of public health, specifically focusing on pharmaceutical science to address global healthcare challenges. His work aims to mitigate resource shortages and reduce the burden of adverse drug reactions through computational science and engineering methodologies. The intended impact is to advance global healthcare outcomes and improve the safety and efficiency of the healthcare system.
View Case

Research Scientist

Healthcare · China

WeGreened EB-2 (NIW) approved
New York 352 days 2025-10-01
The petitioner proposes to employ robust epidemiological studies and statistical methods to investigate urgent public health issues, specifically focusing on prescription drug use, cancer prevention, and treatment. The work aims to generate accessible guidelines for public health researchers, physicians, and government agencies to improve population health outcomes.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-02-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 110 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist